Combined liver and kidney transplantation with particular reference to positive cytotoxic crossmatches by Starzl, TE et al.
T.E. Starzl. A. Tzakis. L. Makowka. J. Fung. G. Klintmalm. S. Todo. R. Gordon. and M. Griffin 
40 
Combined Liver and Kidney Transplantation with 
Particular Reference to Positive 
Cytotoxic Crossmatches 
SUMMARY 
Nine patients were provided with 10 livers and 
10 kidneys. Nine of the paired allografts were from 
the same donors. Seven of the 9 recipients are alive 
after 6 to 26 months. At least 3 and possibly as many 
as 5 of the paired transplantations were to patients 
whose sera possessed preformed antigraft cytotoxic 
antibodies. Only one of the livers seemed harmed by 
the antibodies, and the kidneys that were transplanted 
after the livers were in place were thereby seemingly 
protected from antibody injury in 2 of the 3 unequiv-
ocal cases. These observations may provide a clue 
for the development of new methods to prevent hy-
peracute renal rejection. 
INTRODUCTION 
In a recent inquiry by an Italian journalist, the 
question was posed, "Do you think that in the next 
decade a 'puzzle man' with heart, liver, and pancreas 
taken from other human beings might be feasible?" 
The answer is that there are already examples of puz-
zle men who have received a heart and kidney, a pan-
creas and kidney, a heart and lungs, and even a heart 
and liver taken from other human beings. The in-
creasing boldness with which transplantation is being 
developed makes it certain that other and more com-
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plicated combinations will be forthcoming in the near 
future. 
The extent to which multiple organ transplan-
tation has entered our clinical consciousness could be 
illustrated by any of the foregoing multiple organ 
procedures, particularly by hundreds of cases of 
combined renal and pancreas transplantation. How-
ever, in this communication we will describe the less 
well known combination of hepatic and renal trans-
plantation from common or different donors. The 
subject holds a special fascination, since the liver ap-
parently can protect a subsequently transplanted kid-
ney from the hyperacute rejection that is caused by 
recipient anti-donor cytotoxic antibodies. 
METHODS 
Nine patients aged 12 to 65 years with a variety 
of hepatic and renal diseases were studied. One pa-
tient had a liver plus kidney transplant on two oc-
casions. In each case but one, the primary reason for 
proceeding was end-stage liver disease in which the 
expectation of survival was limited to a few weeks 
or months (Table 1). In the exceptional patient, the 
diagnosis was polycystic liver and renal disease. 
Hepatic function in this patient was normal, but she 
was dying of respiratory insufficiency caused by ex-
pansion of her enormously enlarged liver, which at 
the time of its removal weighed 13 kg (28.6 pounds) 
(Fig. 1). The serum creatinine level in this excep-
tional patient was 2.1 mg%, but her creatinine clear-
ance was estimated at 20 to 25 mL/minute. 
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Fig. 1. Thirteen Kg polycystic liver replaced in pa-
tient OT 464. 
The other 8 patients had various degrees of renal 
insufficiency, ranging from total renal failure (cases 
OT 464 and OT 680) to early renal failure, which 
under ordinary circumstances would not have called 
for immediate treatment by either renal transplanta-
tion or diaJysis (Table 1). Eight of the 9 patients had 
transplantations of both organs from a common do-
nor. The ninth patient (OT 680) had a liver replace-
ment on December 19, 1985. When the preexisting 
renal failure showed no sign of recovery 3 months 
later, an immediately functioning renaJ transplant was 
placed from another donor. 
Tissue matching was random in all cases, and 
the tissue matches at the A , B , and Dr loci were poor 
(Table 2). In 3 of the 10 transplants that were per-
formed in 9 patients, there were unequivocally pos-
itive cytotoxic crossmatches of the kind which, under 
ordinary circumstances, would have precluded renal 
transplantation (Table 2) . In these 3 instances and 
in 2 other patients with doubtfully positive cross-
matches, the liver grafts were placed first, and after 
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a few hours , the kidneys from the same donors were 
inserted. 
Immunosuppressive therapy consisted of cyclo-
sporine (CsA) and prednisone, to which monoclonal 
antibody therapy (OKT3) was added early in the 
postoperative period in 2 patients. The Iymphocyto-
toxic crossmatches were perfomled with conven-
tional techniques as described in detail elsewhere. I 
In the patients who possessed preformed cytotoxic 
antibodies against their donors, the reactivity and 
specificity of the antibodies were assessed with ab-
sorption techniques. I 
The amount of blood lost in the various cases is 
listed in Table 2. The blood loss data was considered 
important because of the possibility of dilution of the 
recipient antibodies by transfusion . 
RESULTS 
Mortality 
One of the 9 recipients died 25 days after an 
initial double organ transplantation and 10 days after 
a second similar attempt. This recipient had been 
treated with liver transplantation in 1979 (6 years 
previously) using azathioprine-steroid maintenance 
therapy. The liver had slowly failed over a period of 
many months during which efforts at salvage were 
made by the late institution of CsA . Renal failure 
which was already present was made worse. The first 
attempt at retransplantation on June 16, 1985 failed 
because of thrombosis of the hepatic artery with sec-
ondary failure of the concomitantly placed kidney. 
The defective liver was removed at another operation 
on June 28 , 1985, leaving in place the kidney graft 
which had not functioned. Although both the liver 
and kidney placed on June 28 functioned, the patient 
died of fungemia 10 days later. 
Patient OT 725 , a 65 year old man , died of 
Pneumocystis carinii pneumonitis 4 months after he-
patic and renal transplantation . He had been treated 
with heavy immunosuppression because of persistent 
and recurrent rejection of both organs . 
Graft Function 
The other 7 patients are well from 6 to 26 months 
postoperatively. All 7 have essentially normal he-
patic function and 6 have weB-functioning renal grafts. 
[n those patients whose pre-existing renal failure was 
not yet poor enough to justify transplantation on such 
grounds alone, radionuclide scans have shown that 
the renal allograft has become the dominant organ 
(Fig. 2) . 
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Table 2. Typing and Serologic Data. 
aT Donor- HLA Panel 
Num- Recipient Antigens Reactive 
ber ABO Matched Antibody 
419 B-8 A29 0% 
464 B-8 0% 
495 A-A 0 94% 
164a 0-0 0 0% 
164b AI, B8 0% 
584 B-8 A2 0% 
680 0-0 Liver AI, 0% 
DR3 
Kidney 0 
708 A-A A2 0% 
725 0-0 0 21% 
736 0-0 A2 91% 
One patient with cystinosis, whose liver had been 
destroyed by an idiosyncratic reaction to experimen-
tal therapy with cysteamine, went through a very 
stonny and protracted postoperative course but even-
tually attained completely nonnal hepatic function. 
Although the renal graft from the same donor has blood 
flow, it has not yet functioned satisfactorily after 6 
months. 
The Influence of Preformed Antigraft 
Antibodies 
Hyperacute rejection of the 3 hepatic grafts that 
were confronted with cytotoxic antidonor antibodies 
did not occur. However, one of the recipients ex-
perienced massive fibrinolysis, which necessitated 
intensive phannacologic and surgical care in an op-
eration that lasted nearly 24 hours. It was suspected 
that the liver had undergone an abortive attack by 
antibodies. Although 50 units of blood were required 
in this small 12-year-old child, the crossmatch with 
the donor remained positive. 
Two of the renal grafts that were put in place 
after the liver had been revascularized functioned 
promptly and permanently. The cytotoxic antibodies 
in these 2 recipients were reduced or had disappeared 
after the liver was in place (Table 2). However, the 
kidney placed in patient OT 736 against a persistent 
cytotoxic crossmatch did not function at the time and 
has not functioned properly in the subsequent 6 
Preop Blood 
Cytotoxic Loss Crossmatch Crossmatch 
Crossmatch (ml) After LTX Later 
Negative 2400 
Doubtful 8000 
positive 
Strongly 3000 Negative Negative 
positive 
Negative 2400 Negative 
Negative 1600 Negative 
Negative 2400 Negative 
Negative Negative 
Doubtful 6000 
positive 
Strongly 8000 Doubtful 
positive positive 
Strongly 20,000 Strongly 
positive positive 
months. Although the renal allograft had fair blood 
flow on a radionuclide scan, it undoubtedly sustained 
a severe and possibly irreversible insult from the an-
tibody attack. 
DISCUSSION 
Patients being considered for liver transplanta-
tion have presented to us with a high incidence of 
secondary renal failure from the hepatorenal syn-
drome, drug toxicity, shock, and other causes. 2.3 Renal 
transplantation in conjunction with hepatic replace-
ment under such circumstances is not usually a se-
rious consideration, since provision of good liver 
function usually corrects the renal pathophysiology; 
complete recovery of the kidneys is expected. Im-
aging techniques such as ultrasound or CT scan are 
invaluable in assessing potential reversibility. If the 
kidneys are small and shrunken, the diagnosis of sig-
nificant chronic renal disease can be considered es-
tablished. 
If chronic renal disease is documented, concom-
itant renal transplantation may be indicated. Com-
bined hepatic and renal transplantation is apt to be-
come more common in the years ahead. Chronic renal 
disease is often seen in patients with end-stage liver 
disease, especially in those in whom the diagnosis is 
chronic active hepatitis, a disease that is frequently 
associated with glomerulonephritis. Other examples 
28 Starzl, et al. 
B 
Fig. 2. Radionuclide can in patient OT 495. Note the dominance of the 
transplant compared with the di eased native kidneys . The upper scan dem-
onstrates flow to the transplant kidney. the lower, secretion. The transplant 
was in the right iliac fossa . 
in our serie were patients with polycystic disease of 
both liver and kidney . In such liver recipients, it would 
be futile to attempt hepatic transplantation without 
providing a kidney as well. . 
ill 7 of our 9 patients, renal transplantation was 
carried out at a stage of chronic renal disease that 
ordinarily would not have been considered appropri-
ate for renal transplantation . There were two reasons 
for proceeding early . First, it was impossible to en-
vision going forward with liver transplantation using 
the nephrotoxic immuno uppressive drug esA, with-
out ensuring good renal fu nction. Otherwise, the op-
timal immunosuppression for the liver would have 
been jeopardized . Second , the sera of a significant 
number of patients contained T-warm cytotoxic an-
tibodies of the kind which preclude renal tran plan-
tation in the event of anti-donor specificity. In the 
event of a positive crossmatch, it was expected that 
the liver would provide protection for the kidney from 
the same donor. thus providing a unique and one time 
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only opportunity for patients whose cytotoxic anti-
bodies were widely reactive. The basis for the spec-
ulation was the well known resistance of the liver to 
hyperacute rejection caused by such antibodies. 4- 6 
This hypothesis was supported not only by the 
clinical observations reported here but also by special 
serologic tests. In patients OT 495 and 725, strongly 
positive crossmatches before the liver was revascu-
larized becan1e negative or doubtfully positive in the 
subsequent hours, allowing the kidneys to be trans-
planted in an antibody depleted milieu. The specific-
ity with which the antibodies were deleted was well 
demonstrated in patient OT 495, whose sera retained 
widely reactive antibodies at the same time as the 
antibodies against the donor lymphocytes were lost. 
This case and others have been reported in detail 
elsewhere.· It is noteworthy that good kidney func-
tion was not obtained in a third patient whose anti-
bodies did not disappear after transplantation of the 
liver. 
Although there was good evidence of immuno-
logic advantage endowed by the liver upon the kid-
ney in the foregoing examples, the long-term effect 
of multiple organ transplantation on the outcome of 
individual organs is not known. Although evidence 
can be cited from numerous publications that multi-
ple organs protect each other, 7 an almost equal num-
ber of citations to the contrary could be found by the 
reader with the converse bias. For the moment, we 
have concluded that neither a clear advantage nor dis-
advantage is demonstrable with multiple organs. 
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